Cargando…
Initiation of Statins After Hospitalization for Coronary Heart Disease
BACKGROUND: Coronary heart disease (CHD) is a major public health problem in the United States. It has been well recognized that patients with prior CHD are at very high risk for recurrent CHD. Statins have been recommended as an effective treatment in the secondary prevention of CHD. OBJECTIVES: To...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437353/ https://www.ncbi.nlm.nih.gov/pubmed/17605510 http://dx.doi.org/10.18553/jmcp.2007.13.5.385 |
_version_ | 1785092503282647040 |
---|---|
author | Ye, Xin Gross, Cynthia R. Schommer, Jon Cline, Richard Xua, Jianwei St. Peter, Wendy L. |
author_facet | Ye, Xin Gross, Cynthia R. Schommer, Jon Cline, Richard Xua, Jianwei St. Peter, Wendy L. |
author_sort | Ye, Xin |
collection | PubMed |
description | BACKGROUND: Coronary heart disease (CHD) is a major public health problem in the United States. It has been well recognized that patients with prior CHD are at very high risk for recurrent CHD. Statins have been recommended as an effective treatment in the secondary prevention of CHD. OBJECTIVES: To (1) determine the proportion of patients who received outpatient statin therapy after CHD hospitalization and (2) identify factors associated with initiation of outpatient statin use. METHODS: Using MedStat MarketScan 1999-2003 databases, CHD hospitalizations (ICD-9-CM codes 410.xx-414.xx, 429.2) between January 1, 2000, and June 30, 2003, were identified, with each patient's first such hospitalization defined as the index hospitalization. The study sample consisted of patients who had had no statin use during the year preceding the index hospitalization and had at least 6 months of follow-up after discharge. Initiation of any statin prescription during follow-up was the outcome of interest. Demographic and clinical predictors were selected with the guidance of Andersen's health services utilization model and past studies. Effects of these independent variables on statin initiation were examined using logistic regression models. RESULTS: Of 17,631 subjects who met the inclusion criteria, only 8,424 (7.8%) had received statin therapy within 6 months after discharge. The following characteristics were inversely related to the likelihood of receiving an outpatient statin: baseline Charlson comorbidity score (6+ vs. 1-2, odds ratio [OR] 0.35; 95% confidence interval [CI], 0.25-0.51), nonacute myocardial infarction CHD hospitalization (OR 0.55; 95% CI, 0.51-0.58), baseline psychoses (OR 0.61; 95% CI, 0.50-0.75), use of lipid-modifying drugs other than statins at baseline (OR 0.61; 95% CI, 0.53-0.71), and patient age (continuous) (OR 0.97; 95% CI, 0.97-0.98). The following characteristics were associated with a higher likelihood of receiving an outpatient statin prescription: hospitalization for CHD in a recent year (2003 vs. 2000, OR 1.77; 95% CI, 1.61-1.94), baseline dyslipidemia (OR 1.54; 95% CI, 1.41-1.68), care by a cardiologist (OR 1.26; 95% CI, 1.18-1.34), and male gender (OR 1.18; 95% CI, 1.10-1.26). In a separate analysis of subjects with complete copayment information (N=13,765), amount of copayment for the first outpatient statin prescription was inversely related to the likelihood of receiving an outpatient statin (e$20 vs. less than$10; OR 0.62; 95% CI, 0.56-0.68). In that equation, hospitalization for CHD in 2003 instead of in 2000 multiplied the odds of receiving statin therapy after discharge by 3.31 (95% CI, 2.95-3.71). CONCLUSIONS: Less than 50% of patients with a CHD hospitalization during the 4-year study period from 2000 through 2003 received outpatient statin therapy within 6 months after discharge, but the proportion increased each year to 56% of patients with a CHD hospitalization in 2003. For CHD patients admitted in 2003, the odds of receiving statin therapy after discharge were approximately 80% to 230% higher than for patients admitted in 2000. Higher statin copayment amount and female gender were associated with lower likelihood of receiving a statin prescription after a CHD hospitalization. |
format | Online Article Text |
id | pubmed-10437353 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2007 |
publisher | Academy of Managed Care Pharmacy |
record_format | MEDLINE/PubMed |
spelling | pubmed-104373532023-08-21 Initiation of Statins After Hospitalization for Coronary Heart Disease Ye, Xin Gross, Cynthia R. Schommer, Jon Cline, Richard Xua, Jianwei St. Peter, Wendy L. J Manag Care Pharm Research BACKGROUND: Coronary heart disease (CHD) is a major public health problem in the United States. It has been well recognized that patients with prior CHD are at very high risk for recurrent CHD. Statins have been recommended as an effective treatment in the secondary prevention of CHD. OBJECTIVES: To (1) determine the proportion of patients who received outpatient statin therapy after CHD hospitalization and (2) identify factors associated with initiation of outpatient statin use. METHODS: Using MedStat MarketScan 1999-2003 databases, CHD hospitalizations (ICD-9-CM codes 410.xx-414.xx, 429.2) between January 1, 2000, and June 30, 2003, were identified, with each patient's first such hospitalization defined as the index hospitalization. The study sample consisted of patients who had had no statin use during the year preceding the index hospitalization and had at least 6 months of follow-up after discharge. Initiation of any statin prescription during follow-up was the outcome of interest. Demographic and clinical predictors were selected with the guidance of Andersen's health services utilization model and past studies. Effects of these independent variables on statin initiation were examined using logistic regression models. RESULTS: Of 17,631 subjects who met the inclusion criteria, only 8,424 (7.8%) had received statin therapy within 6 months after discharge. The following characteristics were inversely related to the likelihood of receiving an outpatient statin: baseline Charlson comorbidity score (6+ vs. 1-2, odds ratio [OR] 0.35; 95% confidence interval [CI], 0.25-0.51), nonacute myocardial infarction CHD hospitalization (OR 0.55; 95% CI, 0.51-0.58), baseline psychoses (OR 0.61; 95% CI, 0.50-0.75), use of lipid-modifying drugs other than statins at baseline (OR 0.61; 95% CI, 0.53-0.71), and patient age (continuous) (OR 0.97; 95% CI, 0.97-0.98). The following characteristics were associated with a higher likelihood of receiving an outpatient statin prescription: hospitalization for CHD in a recent year (2003 vs. 2000, OR 1.77; 95% CI, 1.61-1.94), baseline dyslipidemia (OR 1.54; 95% CI, 1.41-1.68), care by a cardiologist (OR 1.26; 95% CI, 1.18-1.34), and male gender (OR 1.18; 95% CI, 1.10-1.26). In a separate analysis of subjects with complete copayment information (N=13,765), amount of copayment for the first outpatient statin prescription was inversely related to the likelihood of receiving an outpatient statin (e$20 vs. less than$10; OR 0.62; 95% CI, 0.56-0.68). In that equation, hospitalization for CHD in 2003 instead of in 2000 multiplied the odds of receiving statin therapy after discharge by 3.31 (95% CI, 2.95-3.71). CONCLUSIONS: Less than 50% of patients with a CHD hospitalization during the 4-year study period from 2000 through 2003 received outpatient statin therapy within 6 months after discharge, but the proportion increased each year to 56% of patients with a CHD hospitalization in 2003. For CHD patients admitted in 2003, the odds of receiving statin therapy after discharge were approximately 80% to 230% higher than for patients admitted in 2000. Higher statin copayment amount and female gender were associated with lower likelihood of receiving a statin prescription after a CHD hospitalization. Academy of Managed Care Pharmacy 2007-06 /pmc/articles/PMC10437353/ /pubmed/17605510 http://dx.doi.org/10.18553/jmcp.2007.13.5.385 Text en Copyright © 2007, Academy of Managed Care Pharmacy. All rights reserved. https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits unrestricted use and redistribution provided that the original author and source are credited. |
spellingShingle | Research Ye, Xin Gross, Cynthia R. Schommer, Jon Cline, Richard Xua, Jianwei St. Peter, Wendy L. Initiation of Statins After Hospitalization for Coronary Heart Disease |
title | Initiation of Statins After Hospitalization for Coronary Heart Disease |
title_full | Initiation of Statins After Hospitalization for Coronary Heart Disease |
title_fullStr | Initiation of Statins After Hospitalization for Coronary Heart Disease |
title_full_unstemmed | Initiation of Statins After Hospitalization for Coronary Heart Disease |
title_short | Initiation of Statins After Hospitalization for Coronary Heart Disease |
title_sort | initiation of statins after hospitalization for coronary heart disease |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437353/ https://www.ncbi.nlm.nih.gov/pubmed/17605510 http://dx.doi.org/10.18553/jmcp.2007.13.5.385 |
work_keys_str_mv | AT yexin initiationofstatinsafterhospitalizationforcoronaryheartdisease AT grosscynthiar initiationofstatinsafterhospitalizationforcoronaryheartdisease AT schommerjon initiationofstatinsafterhospitalizationforcoronaryheartdisease AT clinerichard initiationofstatinsafterhospitalizationforcoronaryheartdisease AT xuajianwei initiationofstatinsafterhospitalizationforcoronaryheartdisease AT stpeterwendyl initiationofstatinsafterhospitalizationforcoronaryheartdisease |